Term ends Apr 26, 2030 · Medium confidence
20-year base term ends Apr 26, 2030
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 11,110,161), so the cap could be lower.
Apr 26, 2010
Apr 26, 2030
Nov 21, 2023
This patent's term runs 36 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 1 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 26, 2010, when application PCT/EP2010/055507, the earliest non-provisional in its chain, was filed (this one was filed Aug 2, 2021) | Apr 26, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +36 days, USPTO patent term adjustment record | Jun 1, 2030 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,420,827, US 11,110,161, US 8,986,709, US 9,839,683) | capped to Apr 26, 2030 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 26, 2030 | Medium confidence |
This family
| Application 13/266,561 | Abandoned not computed | not computed |
| US 8,986,709 | In force Apr 2030 | Apr 2030 |
| US 9,839,683 | In force Apr 2030 | Apr 2030 |
| US 10,420,827 | In force Apr 2030 | Apr 2030 |
| US 10,653,765 | In force Apr 2030 | Apr 2030 |
| US 11,110,161 | In force no later than Apr 2030 | no later than Apr 2030 |
| US 11,819,545 | this patent Apr 2030 | Apr 2030 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 23, 2024 Reel 68668, frame 854 | Iliad Biotechnologies, LLC | Avenue Capital Management II, L.P. | Security Interest |
| Apr 7, 2026 Reel 74297, frame 442 | Avenue Capital Management II, L.P. | Illiad Biotechnologies, LLC | Release of Security Interest |
| Sep 17, 2026 Reel 76058, frame 408 | Avenue Capital Management II, L.P. | Iliad Biotechnologies, LLC, Now Known as Iliad Biotechnologies, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,420,827, US 11,110,161, US 8,986,709, US 9,839,683.